Area of research
Oncology · Health, Toxicology and Mutagenesis
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Air Quality and Health Impacts, HER2/EGFR in Cancer Research, and Cancer Genomics and Diagnostics.
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Traditional Chinese medicine Jianpi therapy in exercise-induced fatigue
Predictive Value of QRS Fraction for Cardiovascular Death in Patients with Heart Failure: A Prospective Cohort Study in Acute Decompensated Heart Failure (Heb-ADHF)
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function
Developmental Dysplasia of the Hip: An Examination of Care Practices of Pediatric Orthopaedic Surgeons in North America
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study
Progranulin protects against renal ischemia/reperfusion injury in mice
Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis